[Sequential and quantitative analysis of chimerism after non-myeloablative stem cell transplantation]

Area of Science:

• Hematology
• Immunology
• Transplant Science

Context:

• Nonmyeloablative stem cell transplantation (NST) is a critical treatment for hematological diseases.
• Engraftment kinetics and chimerism dynamics post-NST require precise evaluation.
• Predicting transplant outcomes necessitates understanding donor chimerism (DC).

Purpose:

• To investigate the kinetics of donor chimerism (DC).
• To evaluate the outcome of mixed chimerism (MC).
• To determine the prognostic role of chimerism in engraftment, relapse, GVHD, and survival after NST.

Summary:

• Serial STR-PCR analysis showed donor chimerism (DC) dominance by day 8, preceding hematologic engraftment by 4 days.
• Chimeric status converted from mixed chimerism (MC) to full donor chimerism (FDC) post-NST.
• Full donor chimerism (FDC) was associated with higher GVHD rates (90%) compared to MC (62.5%).

Impact:

• Donor chimerism monitoring is valuable for assessing engraftment status post-NST.
• Quantitative chimerism detection aids in predicting patient prognosis and guiding early therapeutic interventions.
• Stable high-level donor chimerism correlates with disease-free survival, while decreasing levels predict relapse or graft rejection.